News

Kazakhstan pharma imports growing
January 18, 2002
Mexico launches TB programme
January 18, 2002
TB drugs market $700 million by 2010
January 18, 2002
Global market data for TB medicines
January 18, 2002
Global fund planning completed
January 18, 2002
World Bank, WHO Announce Global Anti-TB Plan
October 29, 2001
A Troubling Comeback for TB.
October 3, 2001
Update: Fatal and Severe Liver Injuries Associated With Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations -- United States, 2001.
October 3, 2001
Microbacterium tuberculosis inhibits antigen processing.
October 3, 2001
Lives before profit.(tuberculosis drugs)
October 1, 2001
Infectech patents bacterial genomics technology for combating deadly bacteria.
September 27, 2001
Are We Letting Our Guard Down?
September 27, 2001
WHO launches strategy against drug resistance.
September 27, 2001
EASTERN PHARMACIST (INDIA): Hoechst may exit anti-TB market, phase out brands.
September 27, 2001
New Infliximab Indication.
September 27, 2001
Medivir, University of London licensing agreement.
September 27, 2001
Ortho-phthalaldehyde Shows Strong Mycobactericidal Activity.
September 27, 2001
IL-10 Fails To Influence Long-term Course of TB Infection.
September 27, 2001
Sedecim developing IL-16 gene therapy.
September 27, 2001
Sequella, Inc. Announces Launch of New Website: www.sequella.com.
August 20, 2001
Displaying 621 through 640 of 836 items.
« Previous    Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42    Next »    [Show All]